The United States badly bungled coronavirus testing—but things may soon improve
February 28, 2020
Speed is critical in the response to COVID-19. So why has the United States been so slow in its attempt to develop reliable diagnostic tests and use them widely?
The World Health Organization (WHO) has shipped testing kits to 57 countries. China had five commercial tests on the market 1 month ago and can now do up to 1.6 million tests a week; South Korea has tested 65,000 people so far. The U. S. Centers for Disease Control and Prevention (CDC), in contrast, has done only 459 tests since the epidemic began. The rollout of a CDC-designed test kit to state and local labs has become a fiasco because it contained a faulty reagent. Labs around the country eager to test more suspected cases—and test them faster—have been unable to do so. No commercial or state labs have the approval to use their own tests.
In what is already an infamous snafu, CDC initially refused a request to test a patient in Northern California who turned out to be the first probable COVID19 case without known links to an infected person.
The United States badly bungled coronavirus testing—but things may soon improve
Why the CDC botched its coronavirus testing
March 5, 2020
Few health institutions around the world are as renowned as the US Centers for Disease Control and Prevention. Which makes it all the more baffling that the CDC could have fumbled the rollout of coronavirus diagnostic tests throughout the country so badly. While other countries have been able to run millions of tests, the CDC has tested only 1,235 patients. Speed is of the essence when dealing with an epidemic early, and the CDC’s mistakes are already proving costly to tracking the outbreak in the US.
Why the CDC botched its coronavirus testing